Endometriosi

De Viquipèdia
Jump to navigation Jump to search
Infotaula de malaltiaEndometriosi
Endometriosis.jpg
Tipus malaltia del sistema reproductor femení
Especialitat ginecologia
Localització endometri
Medicació danazol Tradueix, hydroxyprogesterone Tradueix, leuprolide Tradueix, norethindrone Tradueix, ethynodiol diacetate Tradueix, desogestrel Tradueix, Nafarelin Tradueix i goserelin acetate Tradueix
Associació genètica PDE1C Tradueix, IL33 Tradueix, VEZT Tradueix, KSR2 Tradueix i GREB1 Tradueix
Classificació
CIM-10 N80
CIM-9 617.0
CIAP X99
Recursos externs
OMIM 131200
DiseasesDB 4269
MedlinePlus 000915
eMedicine 271899 i 795771
Patient UK endometriosis-pro
MeSH D004715 i D004715
UMLS CUI C0014175 i C0014175
DOID DOID:289 i DOID:289
Modifica dades a Wikidata

Endometriosis is a condition in which cells similar to those in the endometrium, the layer of tissue that normally covers the inside of the uterus, grow outside of it.[1][2] Most often this is on the ovaries, Fallopian tubes, and tissue around the uterus and ovaries; however, in rare cases it may also occur in other parts of the body.[3] The main symptoms are pelvic pain and infertility.[4] Nearly half of those affected have chronic pelvic pain, while in 70% pain occurs during menstruation.[4] Pain during sexual intercourse is also common.[4] Infertility occurs in up to half of women affected.[4] Less common symptoms include urinary or bowel symptoms.[4] About 25% of women have no symptoms.[4] Endometriosis can have both social and psychological effects.[5]

The cause is not entirely clear.[4] Risk factors include having a family history of the condition.[3] The areas of endometriosis bleed each month, resulting in inflammation and scarring.[4][3] The growths due to endometriosis are not cancer.[3] Diagnosis is usually based on symptoms in combination with medical imaging,[3] however, biopsy is the most sure method of diagnosis.[3] Other causes of similar symptoms include pelvic inflammatory disease, irritable bowel syndrome, interstitial cystitis, and fibromyalgia.[4]

Tentative evidence suggests that the use of combined oral contraceptives reduces the risk of endometriosis.[6] Exercise and avoiding large amounts of alcohol may also be preventive.[3] There is no cure for endometriosis but a number of treatments may improve symptoms.[4] This may include pain medication, hormonal treatments or surgery.[3] The recommended pain medication is usually a non-steroidal anti-inflammatory drug (NSAID), such as naproxen.[3] Taking the active component of the birth control pill continuously or using an intrauterine device with progestogen may also be useful.[3] Gonadotropin-releasing hormone agonist may improve the ability of those who are infertile to get pregnant.[3] Surgical removal of endometriosis may be used to treat those whose symptoms are not manageable with other treatments.[3]

One estimate is that 10.8 million people are affected globally as of 2015.[7] Other sources estimate about 6–10% of women are affected.[4] Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as 8 years old.[3][8] It results in few deaths.[9] Endometriosis was first determined to be a separate condition in the 1920s.[10] Before that time, endometriosis and adenomyosis were considered together.[10] It is unclear who first described the disease.[10]

History[modifica]

Endometriosis was first discovered microscopically by Karl von Rokitansky in 1860,[11] although it was documented in medical texts more than 4,000 years ago.[12] The Hippocratic Corpus outlines symptoms similar to endometriosis, including uterine ulcers, adhesions, and infertility.[12] Historically, women with these symptoms were treated with leeches, straitjackets, bloodletting, chemical douches, genital mutilation, pregnancy (as a form of treatment), hanging upside down, surgical intervention, and even killing due to suspicion of demonic possession.[12] Hippocratic doctors recognized and treated chronic pelvic pain as a true organic disorder 2,500 years ago, but during the Middle Ages, there was a shift into believing that women with pelvic pain were mad, immoral, imagining the pain, or simply misbehaving.[12] The symptoms of inexplicable chronic pelvic pain were often attributed to imagined madness, female weakness, promiscuity, or hysteria.[12] The historical diagnosis of hysteria, which was thought to be a psychological disease, may have indeed been endometriosis.[12] The idea that chronic pelvic pain was related to mental illness influenced modern attitudes regarding women with endometriosis, leading to delays in correct diagnosis and indifference to the patients' true pain during the 20th century.[12]

Hippocratic doctors believed that delaying childbearing could trigger diseases of the uterus, which caused endometriosis-like symptoms. Women with dysmenorrhea were encouraged to marry and have children at a young age.[12] The fact that Hippocratics were recommending changes in marriage practices due to an endometriosis-like illness implies that this disease was likely common, with rates higher than the 5-15% prevalence that is often cited today.[12] If indeed this disorder was so common historically, this may point away from modern theories that suggest links between endometriosis and dioxins, PCBs, and chemicals.[12]

Signs and symptoms[modifica]

Drawing showing endometriosis

Pain and infertility are common symptoms, although 20-25% of women are asymptomatic.[4]

Pelvic pain[modifica]

A major symptom of endometriosis is recurring pelvic pain. The pain can range from mild to severe cramping or stabbing pain that occurs on both sides of the pelvis, in the lower back and rectal area, and even down the legs. The amount of pain a woman feels correlates weakly with the extent or stage (1 through 4) of endometriosis, with some women having little or no pain despite having extensive endometriosis or endometriosis with scarring, while other women may have severe pain even though they have only a few small areas of endometriosis.[13] Symptoms of endometriosis-related pain may include:

  • dysmenorrhea – painful, sometimes disabling cramps during the menstrual period; pain may get worse over time (progressive pain), also lower back pains linked to the pelvis
  • chronic pelvic pain – typically accompanied by lower back pain or abdominal pain
  • dyspareunia – painful sex
  • dysuria – urinary urgency, frequency, and sometimes painful voiding

Compared with women with superficial endometriosis, those with deep disease appear to be more likely to report shooting rectal pain and a sense of their insides being pulled down.[14] Individual pain areas and pain intensity appear to be unrelated to the surgical diagnosis, and the area of pain unrelated to area of endometriosis.[14]

There are multiple causes of pain. Endometriosis lesions react to hormonal stimulation and may "bleed" at the time of menstruation. The blood accumulates locally if it is not cleared shortly by the immune, circulatory, and lymphatic system. This may further lead to swelling, which triggers inflammation with the activation of cytokines, which results in pain. Another source of pain is the organ dislocation that arises from adhesion binding internal organs to each other. The ovaries, the uterus, the oviducts, the peritoneum, and the bladder can be bound together. Pain triggered in this way can last throughout the menstrual cycle, not just during menstrual periods.[15]

Also, endometriotic lesions can develop their own nerve supply, thereby creating a direct and two-way interaction between lesions and the central nervous system, potentially producing a variety of individual differences in pain that can, in some women, become independent of the disease itself.[13] Nerve fibres and blood vessels are thought to grow into endometriosis lesions by a process known as neuroangiogenesis.[16]

Infertility[modifica]

Plantilla:Main article About a third of women with infertility have endometriosis.[4] Among women with endometriosis about 40% are infertile.[4] The pathogenesis of infertility is dependent on the stage of disease: in early stage disease, it is hypothesised that this is secondary to an inflammatory response that impairs various aspects of conception, whereas in later stage disease distorted pelvic anatomy and adhesions contribute to impaired fertilisation.[17]

Other[modifica]

Other symptoms include diarrhea or constipation,[14] chronic fatigue,Plantilla:Mcn nausea and vomiting, headaches, low-grade fevers, heavy and/or irregular periods, and hypoglycemia.[18][19]

In addition to pain during menstruation, the pain of endometriosis can occur at other times of the month. There can be a pain with ovulation, pain associated with adhesions, pain caused by inflammation in the pelvic cavity, pain during bowel movements and urination, during general bodily movement like exercise, pain from standing or walking, and pain with intercourse. The most severe pain is typically associated with menstruation. Pain can also start a week before a menstrual period, during and even a week after a menstrual period, or it can be constant. The pain can be debilitating and the emotional stress can take a toll.[20]

There is an association between endometriosis and certain types of cancers, notably some types of ovarian cancer,[21][22] non-Hodgkin's lymphoma and brain cancer.[23] Endometriosis is unrelated to endometrial cancer.[24]

Risk factors[modifica]

The cause is not entirely clear.[4] Risk factors include having a family history of the condition.[3]

Genetics[modifica]

Genetic predisposition plays a role.[25] Daughters or sisters of women with endometriosis are at higher risk of developing endometriosis themselves; low progesterone levels may be genetic, and may contribute to a hormone imbalance.[26] There is an about six-fold increased incidence in women with an affected first-degree relative.[27]

It has been proposed that endometriosis results from a series of multiple hits within target genes, in a mechanism similar to the development of cancer.[25] In this case, the initial mutation may be either somatic or heritable.[25]

Individual genomic changes (found by genotyping including genome-wide association studies) that have been associated with endometriosis include:

In addition, there is a weaker association with changes in the fibronectin gene as well as in the 2p14 region of chromosome 2.[28]

There are many findings of altered gene expression and epigenetics, but both of these can also be a secondary result of, for example, environmental factors and altered metabolism. Examples of altered gene expression include that of miRNAs.[25]

Environmental toxins[modifica]

Some factors associated with endometriosis include:

  • not having given birth (nulliparity)[31]
  • prolonged exposure to estrogen; for example, in late menopause[32] or early menarche[33][34]
  • obstruction of menstrual outflow; for example, in Müllerian anomalies[32]

Several studies have investigated the potential link between exposure to dioxins and endometriosis, but the evidence is equivocal and potential mechanisms are poorly understood.[35] A 2004 review of studies of dioxin and endometriosis concluded that "the human data supporting the dioxin-endometriosis association are scanty and conflicting",[36] and a 2009 follow-up review also found that there was "insufficient evidence" in support of a link between dioxin exposure and women developing endometriosis.[37] A 2008 review concluded that more work was needed, stating that "although preliminary work suggests a potential involvement of exposure to dioxins in the pathogenesis of endometriosis, much work remains to clearly define cause and effect and to understand the potential mechanism of toxicity".[38]

Pathophysiology[modifica]

Laparoscopic image of endometriotic lesions at the peritoneum of the pelvic wall

While the exact cause of endometriosis remains unknown, many theories have been presented to better understand and explain its development. These concepts do not necessarily exclude each other. The pathophysiology of endometriosis is likely to be multifactorial and to involve an interplay between several factors.[25]

Formation[modifica]

The main theories for the formation of the ectopic endometrium are retrograde menstruation, Müllerianosis, coelomic metaplasia and transplantation, each further described below.

Retrograde menstruation theory[modifica]

The theory of retrograde menstruation (also called the implantation theory or transplantation theory)[39] is the oldest theory for the formation of ectopic endometrium in endometriosis.[25] It suggests that during a woman's menstrual flow, some of the endometrial debris flow backwards through the Fallopian tubes and into the peritoneal cavity, attaching itself to the peritoneal surface (the lining of the abdominal cavity) where it can proceed to invade the tissue as endometriosis.[25]

Retrograde menstruation alone is not able to explain all instances of endometriosis, and additional factors such as genetic or immune differences need to be invoked to account for the fact that many women with retrograde menstruation do not have endometriosis. In addition, endometriosis has shown up in people who have never experienced menstruation including men,[40] fetuses,[41] and prepubescent girls.[42][43] Further detracting from the retrograde menstruation theory are cases of endometriosis showing up in the brain[44] and lungs.[45] This theory has numerous other associated issues.[46]

Researchers are investigating the possibility that the immune system may not be able to cope with the cyclic onslaught of retrograde menstrual fluid. In this context there is interest in studying the relationship of endometriosis to autoimmune disease, allergic reactions, and the impact of toxic materials.[47][48] It is still unclear what, if any, causal relationship exists between toxic materials, autoimmune disease, and endometriosis. There are immune system changes in women with endometriosis, such as an increase of macrophage-derived secretion products, but it is unknown if these are contributing to the disorder or are reactions from it.[49]

In addition, at least one study found that endometriotic lesions differ in their biochemistry from artificially transplanted ectopic tissue.[50] This is likely because the cells that give rise to endometriosis are a side population of cells.[25] Similarly, there are changes in for example the mesothelium of the peritoneum in women with endometriosis, such as loss of tight junctions, but it is unknown if these are causes or effects of the disorder.[49]

In rare cases where imperforate hymen does not resolve itself prior to the first menstrual cycle and goes undetected, blood and endometrium are trapped within the uterus of the woman until such time as the problem is resolved by surgical incision. Many health care practitioners never encounter this defect, and due to the flu-like symptoms it is often misdiagnosed or overlooked until multiple menstrual cycles have passed. By the time a correct diagnosis has been made, endometrium and other fluids have filled the uterus and Fallopian tubes with results similar to retrograde menstruation resulting in endometriosis. The initial stage of endometriosis may vary based on the time elapsed between onset and surgical procedure.[cal citació]

The theory of retrograde menstruation as a cause of endometriosis was first proposed by John A. Sampson.

Other theories[modifica]

  • Stem cells: Endometriosis may arise from stem cells from bone marrow and potentially other sources. In particular, this theory explains endometriosis found in areas remote from the pelvis such as the brain or lungs.[51]
  • Environment: Environmental toxins (e.g., dioxin, nickel) may cause endometriosis.[52][53]
  • Müllerianosis: A theory supported by foetal autopsy is that cells with the potential to become endometrial, which are laid down in tracts during embryonic development called the female reproductive (Müllerian) tract as it migrates downward at 8–10 weeks of embryonic life, could become dislocated from the migrating uterus and act like seeds or stem cells.[54]
  • Coelomic metaplasia: Coelomic cells which are the common ancestor of endometrial and peritoneal cells may undergo metaplasia (transformation) from one type of cell to the other, perhaps triggered by inflammation.[55]
  • Vasculogenesis: Up to 37% of the microvascular endothelium of ectopic endometrial tissue originates from endothelial progenitor cells, which result in de novo formation of microvessels by the process of vasculogenesis rather than the conventional process of angiogenesis.[56][Cal aclariment]
  • Neural growth: An increased expression of new nerve fibres is found in endometriosis but does not fully explain the formation of ectopic endometrial tissue and is not definitely correlated with the amount of perceived pain.[57][Cal aclariment]
  • Autoimmune: Graves disease is an autoimmune disease characterized by hyperthyroidism, goiter, ophthalmopathy, and dermopathy. Women with endometriosis had higher rates of Graves disease. One of these potential links between Graves disease and endometriosis is autoimmunity.[58][59]

Localization[modifica]

Possible locations of endometriosis

Most often, endometriosis is found on the:

Less common sites are:

Rarely, endometriosis appears in other parts of the body, such as the lungs, brain, and skin.[3]

Rectovaginal or bowel endometriosis affects approximately 5-12% of women with endometriosis, and can cause severe pain with bowel movements.[60]

Endometriosis may spread to the cervix and vagina or to sites of a surgical abdominal incision, known as "scar endometriosis."[61] Risk factors for scar endometriosis include previous abdominal surgeries, such as a hysterotomy or cesarean section, or ectopic pregnancies, salpingostomy puerperal sterilization, laparoscopy, amniocentesis, appendectomy, episiotomy, vaginal hysterectomies, and hernia repair.[62][63][64]

Endometriosis may also present with skin lesions in cutaneous endometriosis.

Less commonly lesions can be found on the diaphragm. Diaphragmatic endometriosis is rare, almost always on the right hemidiaphragm, and may inflict the cyclic pain of the right shoulder just before and during a menstrual period. Rarely, endometriosis can be extraperitoneal and is found in the lungs and CNS.[65]

Diagnosis[modifica]

Transvaginal ultrasonography showing a 67 x 40 mm endometrioma as distinguished from other types of ovarian cysts by a somewhat grainy and not completely anechoic content

A health history and a physical examination can lead the health care practitioner to suspect endometriosis. Although doctors can often feel the endometrial growths during a pelvic exam, and these symptoms may be signs of endometriosis, diagnosis cannot be confirmed by exam only.

In the UK, there is an average of 7.5 years between a woman first seeing a doctor about their symptoms and receiving a firm diagnosis.[66]

Vaginal ultrasound[modifica]

Use of pelvic ultrasound may identify large endometriotic cysts (called endometriomas). However, smaller endometriosis implants cannot be visualized with ultrasound technique.[cal citació]

Vaginal ultrasound has a clinical value in the diagnosis of endometrioma and before operating for deep endometriosis.[67] This applies to the identification of the spread of disease in women with well-established clinical suspicion of endometriosis.[67] Vaginal ultrasound is inexpensive, easily accessible, has no contraindications and requires no preparation.[67] Healthcare professionals conducting ultrasound examinations need to be experienced.[67] By extending the ultrasound assessment into the posterior and anterior pelvic compartments the sonographer is able to evaluate structural mobility and look for deep infiltrating endometriotic nodules noting the size, location and distance from the anus if applicable.[68] An improvement in sonographic detection of deep infiltrating endometriosis will not only reduce the number of diagnostic laparoscopies, it will guide management and enhance quality of life.[68]

Laparoscopy[modifica]

Laparoscopic image of endometriotic lesions in the Pouch of Douglas and on the right sacrouterine ligament

Laparoscopy, a surgical procedure where a camera is used to look inside the abdominal cavity, is the only way to officially diagnose endometriosis as it permits lesion visualization unless the lesion is visible externally (e.g., an endometriotic nodule in the vagina). If the growths are not visible, a biopsy may be taken to determine the diagnosis.[69] Surgery for diagnoses also allows for surgical treatment of endometriosis at the same time.

To the eye, lesions can appear dark blue, powder-burn black, red, white, yellow, brown or non-pigmented. Lesions vary in size. Some within the pelvis walls may not be visible, as normal-appearing peritoneum of infertile women reveals endometriosis on biopsy in 6–13% of cases.[70] Early endometriosis typically occurs on the surfaces of organs in the pelvic and intra-abdominal areas. Health care providers may call areas of endometriosis by different names, such as implants, lesions, or nodules. Larger lesions may be seen within the ovaries as endometriomas or "chocolate cysts", "chocolate" because they contain a thick brownish fluid, mostly old blood.[cal citació]

Frequently during diagnostic laparoscopy, no lesions are found in women with chronic pelvic pain, a symptom common to other disorders including adenomyosis, pelvic adhesions, pelvic inflammatory disease, congenital anomalies of the reproductive tract, and ovarian or tubal masses.[71]

Staging[modifica]

Surgically, endometriosis can be staged I–IV by the revised classification of the American Society of Reproductive Medicine from 1997.[72] The process is a complex point system that assesses lesions and adhesions in the pelvic organs, but it is important to note staging assesses physical disease only, not the level of pain or infertility. A person with Stage I endometriosis may have a little disease and severe pain, while a person with Stage IV endometriosis may have severe disease and no pain or vice versa. In principle the various stages show these findings:Plantilla:Mcn

Stage I (Minimal)
Findings restricted to only superficial lesions and possibly a few filmy adhesions
Stage II (Mild)
In addition, some deep lesions are present in the cul-de-sac
Stage III (Moderate)
As above, plus the presence of endometriomas on the ovary and more adhesions.
Stage IV (Severe)
As above, plus large endometriomas, extensive adhesions.

Markers[modifica]

An area of research is the search for endometriosis markers.[73]

In 2010, essentially all proposed biomarkers for endometriosis were of unclear medical use, although some appear to be promising.[73] The one biomarker that has been in use over the last 20 years is CA-125.[73] A 2016 review found that in those with symptoms of endometriosis; and, once ovarian cancer has been ruled out, a positive CA-125 may confirm the diagnosis.[74] Its performance in ruling out endometriosis, however, is low.[74] CA-125 levels appear to fall during endometriosis treatment, but has not shown a correlation with disease response.[73]

Another review in 2011 identified several putative biomarkers upon biopsy, including findings of small sensory nerve fibers or defectively expressed β3 integrin subunit.[75] It has been postulated a future diagnostic tool for endometriosis will consist of a panel of several specific and sensitive biomarkers, including both substance concentrations and genetic predisposition.[73]

Histopathology[modifica]

Endometriosis, abdominal wall
Micrograph showing endometriosis (right) and ovarian stroma (left). H&E stain.
Micrograph of the wall of an endometrioma. All features of endometriosis are present (endometrial glands, endometrial stroma and hemosiderin-laden macrophages). H&E stain.

Typical endometriotic lesions show histopathologic features similar to endometrium, namely endometrial stroma, endometrial epithelium, and glands that respond to hormonal stimuli. Older lesions may display no glands but hemosiderin deposits (see photomicrograph on right) as residual.[cal citació]

Immunohistochemistry has been found to be useful in diagnosing endometriosis as stromal cells have a peculiar surface antigen, CD10, thus allowing the pathologist go straight to a staining area and hence confirm the presence of stromal cells and sometimes glandular tissue is thus identified that was missed on routine H&E staining.[76]Plantilla:Better source

Pain quantification[modifica]

The most common pain scale for quantification of endometriosis-related pain is the visual analogue scale (VAS); VAS and numerical rating scale (NRS) were the best adapted pain scales for pain measurement in endometriosis. For research purposes, and for more detailed pain measurement in clinical practice, VAS or NRS for each type of typical pain related to endometriosis (dysmenorrhea, deep dyspareunia and non-menstrual chronic pelvic pain), combined with the clinical global impression (CGI) and a quality of life scale, are used.[77]

Prevention[modifica]

Limited evidence indicates that the use of combined oral contraceptives is associated with a reduced risk of endometriosis.[6]

Management[modifica]

While there is no cure for endometriosis, there are two types of interventions; treatment of pain and treatment of endometriosis-associated infertility.[78] In many women, menopause (natural or surgical) will abate the process.[79] In women in the reproductive years, endometriosis is merely managed: the goal is to provide pain relief, to restrict progression of the process, and to restore or preserve fertility where needed. In younger women, surgical treatment attempts to remove endometrial tissue and preserve the ovaries without damaging normal tissue.[80]

In general, the diagnosis of endometriosis is confirmed during surgery, at which time ablative steps can be taken. Further steps depend on circumstances: a woman without infertility can be managed with hormonal medication that suppresses the natural cycle and pain medication, while an infertile woman may be treated expectantly after surgery, with fertility medication, or with IVF. As to the surgical procedure, ablation (or fulguration) of endometriosis (burning and vaporizing the lesions with an electric device) has shown a high rate of short-term recurrence after the procedure. The best surgical procedure with much lower rate of short-term recurrence is to excise (cut and remove) the lesions completely.Plantilla:Mcn

Surgery[modifica]

Conservative treatment consists of the excision of the endometrium, adhesions, resection of endometriomas, and restoration of normal pelvic anatomy as much as is possible.[81] Endometrioma on the ovary of any significant size (Approx. 2 cm +) —sometimes misdiagnosed as ovarian cysts— must be removed surgically because hormonal treatment alone will not remove the full endometrioma cyst, which can progress to acute pain from the rupturing of the cyst and internal bleeding.Plantilla:Mcn Laparoscopy, besides being used for diagnosis, can also be used to perform surgery. It's considered a "minimally invasive" surgery because the surgeon makes very small openings (incisions) at (or around) the belly button and lower portion of the belly. A thin telescope-like instrument (the laparoscope) is placed through one incision, which allows the doctor to look for endometriosis using a small camera attached to the laparoscope. Small instruments are inserted through the incisions to remove the endometriosis tissue and adhesions. Because the incisions are very small, there will only be small scars on the skin after the procedure, and all endometriosis can be removed, and women recover from surgery quicker and have a lower risk of adhesions.[82]

55% to 100% of women develop adhesions following pelvic surgery,[83] which can result in infertility, chronic abdominal and pelvic pain, and difficult reoperative surgery. Trehan's temporary ovarian suspension, a technique in which the ovaries are suspended for a week after surgery may be used to reduce the incidence of adhesions after endometriosis surgery.[84][85]

Conservative treatment involves excision of endometriosis while preserving the ovaries and uterus, very important for women wishing to conceive, but may increase the risk of recurrence.[86]

Endometriosis recurrence following conservative surgery is estimated as 21.5% at 2 years and 40-50% at 5 years.[87]

A hysterectomy (removal of the uterus) can be used to treat endometriosis in women who do not wish to conceive. However, this should only be done when combined with removal of the endometriosis by excision, as if endometriosis is not also removed at the time of hysterectomy, pain may persist.[88]

For women with extreme pain, a presacral neurectomy may be very rarely performed where the nerves to the uterus are cut. However, this technique is almost never used due to the high incidence of associated complications including presacral hematoma and irreversible problems with urination and constipation.[88]

Hormonal medications[modifica]

Vegeu també: Pseudopregnancy
  • Hormonal birth control therapy: Birth control pills reduce the menstrual pain associated with endometriosis.[89] They may function by reducing or eliminating menstrual flow and providing estrogen support. Combined estrogen–progestogen birth control is the first-line treatment for most women with endometriosis due to its ability to be used over long periods of time, relative inexpensiveness and ease of use, and additional benefit of reducing ovarian/endometrial cancer risk.[90]
  • Progestogens: Progesterone counteracts estrogen and inhibits the growth of the endometrium.[91] Such therapy can reduce or eliminate menstruation in a controlled and reversible fashion. Progestins are chemical variants of natural progesterone. An example of a progestin is dienogest (Visanne). Whilst progestogens are often given as part of a combined hormonal therapy with the addition of estrogen, progestogen-only therapy may be an acceptable alternative.
  • Danazol (Danocrine) and gestrinone (Dimetrose, Nemestran) are suppressive steroids with some androgenic activity.[80] Both agents inhibit the growth of endometriosis but their use remains limited as they may cause masculinizing side effects such as excessive hair growth and voice changes.Plantilla:Mcn
  • Gonadotropin-releasing hormone (GnRH) modulators: These drugs include GnRH agonists such as leuprorelin (Lupron) and GnRH antagonists such as elagolix (Orilissa) and are thought to work by decreasing estrogen levels.[92] A 2010 Cochrane review found that GnRH modulators were more effective for pain relief in endometriosis than no treatment or placebo, but were no more effective than danazol or intrauterine progestogen, and had more side effects than danazol.[92] A 2018 Swedish systematic review found that GnRH modulators had similar pain-relieving effects to gestagen, but also decreased bone density.[67]
  • Aromatase inhibitors are medications that block the formation of estrogen and have become of interest for researchers who are treating endometriosis.[93] Examples of aromatase inhibitors include anastrozole and letrozole. Evidence for aromatase inhibitors is limited due to the limited number and quality of studies available, though show promising benefit in terms of pain control.[94]

Other medication[modifica]

  • NSAIDs: Anti-inflammatory. They are commonly used in conjunction with other therapy. For more severe cases narcotic prescription drugs may be used. NSAID injections can be helpful for severe pain or if stomach pain prevents oral NSAID use. Examples of NSAIDs include ibuprofen and naproxen.
  • Opioids: Morphine sulphate tablets and other opioid painkillers work by mimicking the action of naturally occurring pain-reducing chemicals called "endorphins". There are different long acting and short acting medications that can be used alone or in combination to provide appropriate pain control.
  • Following laparoscopic surgery women who were given Chinese herbs were reported to have comparable benefits to women with conventional drug treatments, though the journal article that reviewed this study also noted that "the two trials included in this review are of poor methodological quality so these findings must be interpreted cautiously. Better quality randomised controlled trials are needed to investigate a possible role for CHM [Chinese Herbal Medicine] in the treatment of endometriosis."[95]
  • Pentoxifylline, an immunomodulating agent, has been theorized to improve pain as well as improve pregnancy rates in women with endometriosis. A 2012 Cochrane review, however, found that there was not enough evidence to support the effectiveness or safety of either of these uses.[96] Current American Congress of Obstetricians and Gynecologists (ACOG) guidelines do not include immune-modulators, such as pentoxifylline, in standard treatment protocols.[97]
  • Angiogenesis inhibitors lack clinical evidence of efficacy in endometriosis therapy.[98] Under experimental in vitro and in vivo conditions, compounds that have been shown to exert inhibitory effects on endometriotic lesions include growth factor inhibitors, endogenous angiogenesis inhibitors, fumagillin analogues, statins, cyclo-oxygenase-2 inhibitors, phytochemical compounds, immunomodulators, dopamine agonists, peroxisome proliferator-activated receptor agonists, progestins, danazol and gonadotropin-releasing hormone agonists.[98] However, many of these agents are associated with undesirable side effects and more research is necessary. An ideal therapy would diminish inflammation and underlying symptoms without being contraceptive.[99][100]

The overall effectiveness of manual physical therapy to treat endometriosis has not yet been identified.[101] There is no evidence to support nutritional therapy as effective.

Comparison of interventions[modifica]

Medicinal and surgical interventions produce roughly equivalent pain-relief benefits. Recurrence of pain was found to be 44 and 53 percent with medicinal and surgical interventions, respectively.[26] Each approach has advantages and disadvantages.[55] Manual therapy showed a decrease in pain for 84 percent of study participants, and a 93 percent improvement in sexual function.Plantilla:MEDRS[102]

A data de 2013 evidence on how effective medication is for relieving pain associated with endometriosis was limited .[78] A 2018 Swedish systematic review found a large number of studies but a general lack of scientific evidence for most treatments.[67] There was only one study of sufficient quality and relevance comparing the effect of surgery and non-surgery.[103] Cohort studies indicate that surgery is effective in decreasing pain.[103] Most complications occurred in cases of low intestinal anastomosis, while risk of fistula occurred in cases of combined abdominal or vaginal surgery, and urinary tract problems were common in intestinal surgery.[103] The evidence was found to be insufficient regarding surgical intervention.[103]

The advantages of surgery are demonstrated efficacy for pain control,[104] it is more effective for infertility than medicinal intervention,[80] it provides a definitive diagnosis,[80] and surgery can often be performed as a minimally invasive (laparoscopic) procedure to reduce morbidity and minimize the risk of post-operative adhesions.[105] Efforts to develop effective strategies to reduce or prevent adhesions have been undertaken, but their formation remain a frequent side effect of abdominal surgery.[83]

The advantages of physical therapy techniques are decreased cost, absence of major side-effects, it does not interfere with fertility, and near-universal increase of sexual function.[102] Disadvantages are that there are no large or long-term studies of its use for treating pain or infertility related to endometriosis.[102]

Treatment of infertility[modifica]

Plantilla:Main article Surgery is more effective than medicinal intervention for addressing infertility associated with endometriosis.[80] Surgery attempts to remove endometrial tissue and preserve the ovaries without damaging normal tissue.[80] In-vitro fertilization (IVF) procedures are effective in improving fertility in many women with endometriosis.Plantilla:Mcn

During fertility treatment, the ultralong pretreatment with GnRH-agonist has a higher chance of resulting in pregnancy for women with endometriosis, compared to the short pretreatment.[67]

Outcomes[modifica]

Proper counseling of women with endometriosis requires attention to several aspects of the disorder. Of primary importance is the initial operative staging of the disease to obtain adequate information on which to base future decisions about therapy. The woman's symptoms and desire for childbearing dictate appropriate therapy. Not all therapy works for all women. Some women have recurrences after surgery or pseudo-menopause. In most cases, treatment will give women significant relief from pelvic pain and assist them in achieving pregnancy.[106]

The underlying process that causes endometriosis may not cease after a surgical or medical intervention. Studies have shown that endometriosis recurs at a rate of 20 to 40 percent within five years following conservative surgery,Plantilla:MEDRS[107] unless hysterectomy is performed or menopause reached. Monitoring of women consists of periodic clinical examinations and sonography.

Complications[modifica]

Complications of endometriosis include internal scarring, adhesions, pelvic cysts, chocolate cysts of ovaries, ruptured cysts, and bowel and ureter obstruction resulting from pelvic adhesions.[108] Endometriosis-associated infertility can be related to scar formation and anatomical distortions due to the endometriosis.[3]

Ovarian endometriosis may complicate pregnancy by decidualization, abscess and/or rupture.[109]

Thoracic endometriosis is associated with recurrent pneumothoraces at times of a menstrual period, termed catamenial pneumothorax.[110]

A 20-year study of 12,000 women with endometriosis found that women under 40 who are diagnosed with endometriosis are 3 times more likely to have heart problems than their healthy peers.[111][112]

It results in few deaths.[9]

Epidemiology[modifica]

One estimate is that 10.8 million people are affected globally as of 2015.[7] Other sources estimate about 6–10% of women are affected.[4] It may affect more than 11% of American women between 15 and 44.[3] Endometriosis is most common in those in their thirties and forties; however, it can begin in girls as early as 8 years old.[3][8]

It can affect any female, from premenarche to postmenopause, regardless of race or ethnicity or whether or not they have had children. It is primarily a disease of the reproductive years.[113] Incidences of endometriosis have occurred in postmenopausal women,[114] and in less common cases, girls may have endometriosis symptoms before they even reach menarche.[115][116]

Society and culture[modifica]

As recently as 1995, reports found that over 50% of women with chronic pelvic pain had no organic cause, with women still often being considered mentally unstable.[117] Self-help groups say practitioners delay making the diagnosis, often because they do not consider it a possibility. In the US, as of 2007, about 27% of women with endometriosis had had the symptoms for at least six years before it is diagnosed.[118]

The economic effects associated with endometriosis are substantial and are similar to that of other chronic diseases such as Crohn's disease, diabetes, or rheumatoid arthritis.[119] This economic burden is attributed mostly to the inability to consistently work and predicted by decreased quality of life.[119]

Referències[modifica]

  1. «Endometriosis: Overview» (en en-us). Arxivat de l'original el 18 May 2017.
  2. «Endometriosis: Condition Information» (en en-us). Arxivat de l'original el 30 April 2017.
  3. 3,00 3,01 3,02 3,03 3,04 3,05 3,06 3,07 3,08 3,09 3,10 3,11 3,12 3,13 3,14 3,15 3,16 3,17 3,18 3,19 «Endometriosis» (en en), 13-02-2017. Arxivat de l'original el 13 May 2017.
  4. 4,00 4,01 4,02 4,03 4,04 4,05 4,06 4,07 4,08 4,09 4,10 4,11 4,12 4,13 4,14 4,15 «Endometriosis and infertility». Journal of Assisted Reproduction and Genetics, vol. 27, 8, August 2010, pàg. 441–7. DOI: 10.1007/s10815-010-9436-1. PMC: 2941592. PMID: 20574791.
  5. «The social and psychological impact of endometriosis on women's lives: a critical narrative review». Human Reproduction Update, vol. 19, 6, 01-11-2013, pàg. 625–39. DOI: 10.1093/humupd/dmt027. PMID: 23884896.
  6. 6,0 6,1 «Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis». Human Reproduction Update, vol. 17, 2, 01-03-2011, pàg. 159–70. DOI: 10.1093/humupd/dmq042. PMID: 20833638.
  7. 7,0 7,1 «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet, vol. 388, 10053, October 2016, pàg. 1545–1602. DOI: 10.1016/S0140-6736(16)31678-6. PMC: 5055577. PMID: 27733282.
  8. 8,0 8,1 McGrath, Patrick J.; Stevens, Bonnie J.; Walker, Suellen M. [et al]. Oxford Textbook of Paediatric Pain (en en). OUP Oxford, 2013, p. 300. ISBN 9780199642656. 
  9. 9,0 9,1 «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013». Lancet, vol. 385, 9963, January 2015, pàg. 117–71. DOI: 10.1016/S0140-6736(14)61682-2. PMC: 4340604. PMID: 25530442.
  10. 10,0 10,1 10,2 Endometriosis: Science and Practice. John Wiley & Sons, 2012, p. 3. ISBN 9781444398496. 
  11. Batt, Ronald E. A history of endometriosis. London: Springer, 2011, p. 13–38. ISBN 978-0-85729-585-9. 
  12. 12,0 12,1 12,2 12,3 12,4 12,5 12,6 12,7 12,8 12,9 «Endometriosis: ancient disease, ancient treatments». Fertility and Sterility, vol. 98, 6 Suppl, December 2012, pàg. S1-62. DOI: 10.1016/j.fertnstert.2012.08.001. PMID: 23084567.
  13. 13,0 13,1 «Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications». Human Reproduction Update, vol. 17, 3, 2011, pàg. 327–46. DOI: 10.1093/humupd/dmq050. PMC: 3072022. PMID: 21106492.
  14. 14,0 14,1 14,2 «Can specific pain symptoms help in the diagnosis of endometriosis? A cohort study of women with chronic pelvic pain». Fertility and Sterility, vol. 94, 1, June 2010, pàg. 20–7. DOI: 10.1016/j.fertnstert.2009.01.164. PMID: 19342028.
  15. [Pàgina?] The Encyclopedia of Natural Medicine. 3rd. New York, NY: Simon and Schuster, 2012. 
  16. «Endometriosis: the role of neuroangiogenesis». Annual Review of Physiology, vol. 73, 2011, pàg. 163–82. DOI: 10.1146/annurev-physiol-012110-142158. PMID: 21054165.
  17. «Treatment of infertility in women with endometriosis».
  18. Wolthuis, Albert M; Meuleman, Christel; Tomassetti, Carla; D’Hooghe, Thomas; de Buck van Overstraeten, Anthony. «Bowel endometriosis: Colorectal surgeon’s perspective in a multidisciplinary surgical team» p. 15616–15623, 14-11-2014. DOI: 10.3748/wjg.v20.i42.15616.
  19. «Endometriosis can evade diagnosis». Rn, vol. 71, 9, September 2008, pàg. 28–32; quiz 33. PMID: 18833741.
  20. «Are aromatase inhibitors effective in endometriosis treatment?». Expert Opinion on Investigational Drugs, vol. 20, 7, July 2011, pàg. 917–31. DOI: 10.1517/13543784.2011.581226. PMID: 21529311.
  21. «Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies». The Lancet. Oncology, vol. 13, 4, April 2012, pàg. 385–94. DOI: 10.1016/S1470-2045(11)70404-1. PMC: 3664011. PMID: 22361336.
  22. Nezhat F. Article by Prof. Farr Nezhat, MD, FACOG, FACS, University of Columbia, May 1, 2012 Arxivat November 2, 2012, at the Wayback Machine.
  23. «[Women with endometriosis: are they different from others?]» (en french). Gynecologie, Obstetrique & Fertilite, vol. 33, 4, April 2005, pàg. 239–46. DOI: 10.1016/j.gyobfe.2005.03.010. PMID: 15894210.
  24. «Gynecological conditions and the risk of endometrial cancer». Gynecologic Oncology, vol. 123, 3, December 2011, pàg. 537–41. DOI: 10.1016/j.ygyno.2011.08.022. PMID: 21925719.
  25. 25,0 25,1 25,2 25,3 25,4 25,5 25,6 25,7 «Contemporary genetic technologies and female reproduction». Human Reproduction Update, vol. 17, 6, 2011, pàg. 829–47. DOI: 10.1093/humupd/dmr033. PMC: 3191938. PMID: 21896560.
  26. 26,0 26,1 Kapoor D, Davila W (2005). Endometriosis, Arxivat 2007-11-11 at the Wayback Machine. eMedicine.
  27. «Endometriosis». Lancet, vol. 364, 9447, 2004, pàg. 1789–99. DOI: 10.1016/S0140-6736(04)17403-5. PMID: 15541453.
  28. 28,0 28,1 28,2 28,3 28,4 28,5 28,6 «Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets». Human Reproduction Update, vol. 20, 5, 2014, pàg. 702–16. DOI: 10.1093/humupd/dmu015. PMC: 4132588. PMID: 24676469.
  29. «Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis». Nature Genetics, vol. 43, 1, January 2011, pàg. 51–4. DOI: 10.1038/ng.731. PMC: 3019124. PMID: 21151130.
  30. «Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26». American Journal of Human Genetics, vol. 77, 3, September 2005, pàg. 365–76. DOI: 10.1086/432960. PMC: 1226203. PMID: 16080113.
  31. «Differences in characteristics among 1,000 women with endometriosis based on extent of disease». Fertility and Sterility, vol. 89, 3, March 2008, pàg. 538–45. DOI: 10.1016/j.fertnstert.2007.03.069. PMC: 2939902. PMID: 17498711.
  32. 32,0 32,1 «Clinical practice. Endometriosis». The New England Journal of Medicine, vol. 362, 25, June 2010, pàg. 2389–98. DOI: 10.1056/NEJMcp1000274. PMC: 3108065. PMID: 20573927.
  33. «Early menstrual characteristics associated with subsequent diagnosis of endometriosis». American Journal of Obstetrics and Gynecology, vol. 202, 6, June 2010, pàg. 534.e1-6. DOI: 10.1016/j.ajog.2009.10.857. PMID: 20022587.
  34. «Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of case-control studies». Fertility and Sterility, vol. 98, 3, September 2012, pàg. 702–712.e6. DOI: 10.1016/j.fertnstert.2012.05.035. PMC: 3502866. PMID: 22728052.
  35. «The link between environmental toxicant exposure and endometriosis». Frontiers in Bioscience, vol. 13, January 2008, pàg. 1578–93. DOI: 10.2741/2782. PMID: 17981650.
  36. «The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data». Gynecologic and Obstetric Investigation, vol. 57, 3, 2004, pàg. 157–73. DOI: 10.1159/000076374. PMID: 14739528.
  37. «Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology». Molecular Human Reproduction, vol. 15, 10, October 2009, pàg. 609–24. DOI: 10.1093/molehr/gap075. PMID: 19744969.
  38. «Environmental dioxins and endometriosis». Toxicological Sciences, vol. 70, 2, December 2002, pàg. 161–70. DOI: 10.1093/toxsci/70.2.161. PMID: 12441361.
  39. «Theories on the pathogenesis of endometriosis». Human Reproduction, vol. 11 Suppl 3, November 1996, pàg. 53–65. DOI: 10.1093/humrep/11.suppl_3.53. PMID: 9147102.
  40. «Endometriosis of the urinary bladder in a man with prostatic carcinoma». Cancer, vol. 43, 4, April 1979, pàg. 1562–7. DOI: 10.1002/1097-0142(197904)43:4%3C1562::aid-cncr2820430451%3E3.0.co;2-w. PMID: 445352.
  41. «Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer». Journal of Experimental & Clinical Cancer Research, vol. 28, April 2009, pàg. 49. DOI: 10.1186/1756-9966-28-49. PMC: 2671494. PMID: 19358700.
  42. «Endometriosis in a patient with Mayer-Rokitansky-Küster-Hauser syndrome and complete uterine agenesis: evidence to support the theory of coelomic metaplasia». Journal of Pediatric and Adolescent Gynecology, vol. 23, 1, February 2010, pàg. e35-7. DOI: 10.1016/j.jpag.2009.02.010. PMID: 19589710.
  43. «Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly». Fertility and Sterility, vol. 83, 3, March 2005, pàg. 758–60. DOI: 10.1016/j.fertnstert.2004.08.025. PMID: 15749511.
  44. «Cerebral endometriosis. Case report». Journal of Neurosurgery, vol. 66, 4, April 1987, pàg. 609–10. DOI: 10.3171/jns.1987.66.4.0609. PMID: 3559727.
  45. «Catamenial hemoptysis due to bronchial endometriosis». The New England Journal of Medicine, vol. 266, 16, April 1962, pàg. 805–8. DOI: 10.1056/nejm196204192661604. PMID: 14493132.
  46. «Endopædia».
  47. «Is endometriosis an autoimmune disease?». Obstetrics and Gynecology, vol. 70, 1, July 1987, pàg. 115–22. PMID: 3110710.
  48. «Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis». Annals of the New York Academy of Sciences, vol. 1069, June 2006, pàg. 263–7. DOI: 10.1196/annals.1351.024. PMID: 16855153.
  49. 49,0 49,1 «The role of the peritoneum in the pathogenesis of endometriosis». Human Reproduction Update, vol. 19, 5, 2013, pàg. 558–69. DOI: 10.1093/humupd/dmt024. PMID: 23720497.
  50. «Was Sampson wrong?». Fertility and Sterility, vol. 78, 4, October 2002, pàg. 686–93. DOI: 10.1016/S0015-0282(02)03329-0. PMID: 12372441.
  51. «The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis». Seminars in Reproductive Medicine, vol. 33, 5, September 2015, pàg. 333–40. DOI: 10.1055/s-0035-1564609. PMC: 4986990. PMID: 26375413.
  52. «Dioxin may promote inflammation-related development of endometriosis». Fertility and Sterility, vol. 89, 5 Suppl, May 2008, pàg. 1287–98. DOI: 10.1016/j.fertnstert.2008.02.102. PMC: 2430157. PMID: 18394613.
  53. «Nickel Allergy Is a Risk Factor for Endometriosis: An 11-Year Population-Based Nested Case-Control Study». PLOS One, vol. 10, 10, 2015, pàg. e0139388. DOI: 10.1371/journal.pone.0139388. PMC: 4594920. PMID: 26439741.
  54. «Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer». Journal of Experimental & Clinical Cancer Research, vol. 28, April 2009, pàg. 49. DOI: 10.1186/1756-9966-28-49. PMC: 2671494. PMID: 19358700.
  55. 55,0 55,1 «Diagnosis and Treatment of Endometriosis». American Academy of Family Physicians, 15-10-1999. Arxivat de l'original el 2011-06-06. [Consulta: 26 juliol 2011].
  56. «Vasculogenesis: a new piece of the endometriosis puzzle». Human Reproduction Update, vol. 17, 5, 2011, pàg. 628–36. DOI: 10.1093/humupd/dmr023. PMID: 21586449.
  57. «Peripheral changes in endometriosis-associated pain». Human Reproduction Update, vol. 20, 5, 2014, pàg. 717–36. DOI: 10.1093/humupd/dmu021. PMC: 4337970. PMID: 24859987.
  58. «Graves Disease Is Associated With Endometriosis: A 3-Year Population-Based Cross-Sectional Study». Medicine, vol. 95, 10, March 2016, pàg. e2975. DOI: 10.1097/MD.0000000000002975. PMC: 4998884. PMID: 26962803.
  59. «Endometriosis». Lancet, vol. 364, 9447, 2004, pàg. 1789–99. DOI: 10.1016/S0140-6736(04)17403-5. PMID: 15541453.
  60. «Endometriosis of the bowel». Obstetrics and Gynecology, vol. 69, 5, May 1987, pàg. 727–30. PMID: 3574800.
  61. «Scar endometriosis: a case report of this uncommon entity and review of the literature». Case Reports in Obstetrics and Gynecology, vol. 2013, 2013, pàg. 386783. DOI: 10.1155/2013/386783. PMC: 3665185. PMID: 23762683.
  62. «Abdominal wall endometriomas». Digestive Diseases and Sciences, vol. 47, 2, February 2002, pàg. 456–61. DOI: 10.1023/a:1013711314870. PMID: 11855568.
  63. «Needle tract endometriosis: an unusual complication of amniocentesis». Obstetrics and Gynecology, vol. 54, 6, December 1979, pàg. 753–5. PMID: 160025.
  64. «Surgical scar endometrioma». Surgery, Gynecology & Obstetrics, vol. 177, 3, September 1993, pàg. 243–6. PMID: 8356497.
  65. Daly S. «Endometrioma/Endometriosis». WebMD, October 18, 2004. Arxivat de l'original el February 6, 2007. [Consulta: 19 desembre 2006].
  66. «Getting diagnosed with endometriosis | Endometriosis UK» (en en).
  67. 67,0 67,1 67,2 67,3 67,4 67,5 67,6 «Endometriosis – Diagnosis, treatment and patient experiences» (en en). Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), 04-05-2018.
  68. 68,0 68,1 Fang, Jing; Piessens, Sofie «A step-by-step guide to sonographic evaluation of deep infiltrating endometriosis» (en en). Sonography, vol. 5, 2, 04-06-2018, pàg. 67–75. DOI: 10.1002/sono.12149. ISSN: 2202-8323.
  69. Office on Women’s Health, U.S. Department of Health and Human Services. (16 July 2012). Endometriosis Fact Sheet. Retrieved from Womenshealth.gov «Archived copy». Arxivat de l'original el 2015-07-03. [Consulta: 11 juliol 2015].
  70. «Histologic study of peritoneal endometriosis in infertile women». Fertility and Sterility, vol. 53, 6, June 1990, pàg. 984–8. PMID: 2351237.
  71. «Treatment of pelvic pain associated with endometriosis: a committee opinion». Fertility and Sterility, vol. 101, 4, April 2014, pàg. 927–35. DOI: 10.1016/j.fertnstert.2014.02.012. PMID: 24630080.
  72. «Revised American Society for Reproductive Medicine classification of endometriosis: 1996». Fertility and Sterility, vol. 67, 5, May 1997, pàg. 817–21. DOI: 10.1016/S0015-0282(97)81391-X. PMID: 9130884.
  73. 73,0 73,1 73,2 73,3 73,4 «Peripheral biomarkers of endometriosis: a systematic review». Human Reproduction Update, vol. 16, 6, 2010, pàg. 651–74. DOI: 10.1093/humupd/dmq009. PMC: 2953938. PMID: 20462942.
  74. 74,0 74,1 «Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis». Bjog, vol. 123, 11, October 2016, pàg. 1761–8. DOI: 10.1111/1471-0528.14055. PMID: 27173590.
  75. «Endometrial alterations in endometriosis: a systematic review of putative biomarkers». Human Reproduction Update, vol. 17, 5, 2011, pàg. 637–53. DOI: 10.1093/humupd/dmr013. PMID: 21672902.
  76. «Archived copy». Arxivat de l'original el 2013-05-02. [Consulta: 18 juliol 2013].
  77. «Systematic review of endometriosis pain assessment: how to choose a scale?». Human Reproduction Update, vol. 21, 1, 2014, pàg. 136–52. DOI: 10.1093/humupd/dmu046. PMID: 25180023.
  78. 78,0 78,1 «What are the treatments for endometriosis». Eunice Kennedy Shriver National Institute of Child Health and Human Development. Arxivat de l'original el 3 August 2013. [Consulta: 20 agost 2013].
  79. «EMAS position statement: Managing the menopause in women with a past history of endometriosis». Maturitas, vol. 67, 1, September 2010, pàg. 94–7. DOI: 10.1016/j.maturitas.2010.04.018. PMID: 20627430.
  80. 80,0 80,1 80,2 80,3 80,4 80,5 «Diagnosis and treatment of endometriosis». American Family Physician, vol. 60, 6, October 1999, pàg. 1753–62, 1767–8. PMID: 10537390.
  81. Clinical Gynecologic Endocrinology and Infertility. 6th. Lippincott Willimas Wilkins, 1999, p. 1057. ISBN 0-683-30379-1. 
  82. «Endometriosis and Infertility: Can Surgery Help?». American Society for Reproductive Medicine, 2008. Arxivat de l'original el 2010-10-11. [Consulta: 31 octubre 2010].
  83. 83,0 83,1 «Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management». Digestive Surgery, vol. 18, 4, 2001, pàg. 260–73. DOI: 10.1159/000050149. PMID: 11528133.
  84. «Temporary ovarian suspension». Gynaecological Endoscopy, vol. 11, 1, 2002, pàg. 309–314. DOI: 10.1046/j.1365-2508.2002.00520.x.
  85. «Temporary ovarian suspension at laparoscopy for prevention of adhesions». The Journal of the American Association of Gynecologic Laparoscopists, vol. 9, 1, February 2002, pàg. 98–102. PMID: 11821616.
  86. «Incidence of symptom recurrence after hysterectomy for endometriosis». Fertility and Sterility, vol. 64, 5, November 1995, pàg. 898–902. PMID: 7589631.
  87. «Recurrence of endometriosis and its control». Human Reproduction Update, vol. 15, 4, 2009, pàg. 441–61. DOI: 10.1093/humupd/dmp007. PMID: 19279046.
  88. 88,0 88,1 «Consensus on current management of endometriosis». Human Reproduction, vol. 28, 6, June 2013, pàg. 1552–68. DOI: 10.1093/humrep/det050. PMID: 23528916.
  89. «Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review». Archives of Gynecology and Obstetrics, vol. 292, 1, July 2015, pàg. 37–43. DOI: 10.1007/s00404-015-3641-1. PMID: 25644508.
  90. «Endometriosis: Treatment of pelvic pain».
  91. «Role of nuclear progesterone receptor isoforms in uterine pathophysiology». Human Reproduction Update, vol. 21, 2, 2014, pàg. 155–73. DOI: 10.1093/humupd/dmu056. PMC: 4366574. PMID: 25406186.
  92. 92,0 92,1 «Gonadotrophin-releasing hormone analogues for pain associated with endometriosis». The Cochrane Database of Systematic Reviews, 12, December 2010, pàg. CD008475. DOI: 10.1002/14651858.CD008475.pub2. PMID: 21154398.
  93. «Aromatase inhibitors: the next generation of therapeutics for endometriosis?». Fertility and Sterility, vol. 85, 5, May 2006, pàg. 1307–18. DOI: 10.1016/j.fertnstert.2005.09.064. PMID: 16647373.
  94. «Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis». Bjog, vol. 115, 7, June 2008, pàg. 818–22. DOI: 10.1111/j.1471-0528.2008.01740.x. PMID: 18485158.
  95. «Chinese herbal medicine for endometriosis». The Cochrane Database of Systematic Reviews, 5, May 2012, pàg. CD006568. DOI: 10.1002/14651858.CD006568.pub3. PMID: 22592712.
  96. «Pentoxifylline for endometriosis». The Cochrane Database of Systematic Reviews, vol. 1, January 2012, pàg. CD007677. DOI: 10.1002/14651858.CD007677.pub3. PMID: 22258970.
  97. «Practice bulletin no. 114: management of endometriosis». Obstetrics and Gynecology, vol. 116, 1, July 2010, pàg. 223–36. DOI: 10.1097/AOG.0b013e3181e8b073. PMID: 20567196.
  98. 98,0 98,1 «Anti-angiogenic treatment strategies for the therapy of endometriosis». Human Reproduction Update, vol. 18, 6, 2012, pàg. 682–702. DOI: 10.1093/humupd/dms026. PMID: 22718320.
  99. «The role of lipoxin A4 in endometrial biology and endometriosis». Mucosal Immunology, vol. 6, 3, May 2013, pàg. 439–50. DOI: 10.1038/mi.2013.9. PMC: 4062302. PMID: 23485944.
  100. «An update on the pharmacological management of endometriosis». Expert Opinion on Pharmacotherapy, vol. 14, 3, February 2013, pàg. 291–305. DOI: 10.1517/14656566.2013.767334. PMID: 23356536.
  101. «The effects of massage therapy on dysmenorrhea caused by endometriosis». Iranian Journal of Nursing and Midwifery Research, vol. 15, 4, 2010, pàg. 167–71. PMC: 3093183. PMID: 21589790.
  102. 102,0 102,1 102,2 Plantilla:Primary-source inline «Decreasing dyspareunia and dysmenorrhea in women with endometriosis via a manual physical therapy: Results from two independent studies». Journal of Endometriosis and Pelvic Pain Disorders, vol. 3, 2011, pàg. 188–196. DOI: 10.5301/JE.2012.9088.
  103. 103,0 103,1 103,2 103,3 «Endometrios – diagnostik, behandling och bemötande» (en sv). Statens beredning för medicinsk och social utvärdering (SBU); Swedish Agency for Health Technology Assessment and Assessment of Social Services.
  104. «The influence of peritoneal endometriotic lesions on the generation of endometriosis-related pain and pain reduction after surgical excision». Archives of Gynecology and Obstetrics, vol. 280, 3, September 2009, pàg. 369–73. DOI: 10.1007/s00404-008-0921-z. PMID: 19148660.
  105. «Coagulation versus excision of primary superficial endometriosis: a 2-year follow-up». European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 150, 2, June 2010, pàg. 195–8. DOI: 10.1016/j.ejogrb.2010.02.022. PMID: 20303642.
  106. «Endometriosis». Differential Diagnosis and Treatment of endometriosis.. Armenian Health Network, Health.am, September 21, 2006. Arxivat de l'original el January 31, 2007. [Consulta: 19 desembre 2006].
  107. Plantilla:MEDRS «Recurrent Endometriosis: Surgical Management». Endometriosis. The Cleveland Clinic, 07-01-2010. Arxivat de l'original el 2010-05-01. [Consulta: 31 octubre 2010].
  108. «[A case report. Endometriosis caused colonic ileus, ureteral obstruction and hypertension]» (en swedish). Lakartidningen, vol. 98, 18, May 2001, pàg. 2208–12. PMID: 11402601.
  109. «A retrospective analysis of ovarian endometriosis during pregnancy». Fertility and Sterility, vol. 94, 1, June 2010, pàg. 78–84. DOI: 10.1016/j.fertnstert.2009.02.092. PMID: 19356751.
  110. «Catamenial pneumothorax». Journal of Thoracic Disease, vol. 6, Suppl 4, October 2014, pàg. S448-60. DOI: 10.3978/j.issn.2072-1439.2014.08.49. PMC: 4203986. PMID: 25337402.
  111. Wise, Jacqui «Women with endometriosis show higher risk for heart disease» (en en). BMJ, vol. 353, 01-04-2016, pàg. i1851. DOI: 10.1136/bmj.i1851. ISSN: 1756-1833. PMID: 27036948.
  112. «Women with endometriosis at higher risk for heart disease | American Heart Association» (en en).
  113. «The emerging use of aromatase inhibitors for endometriosis treatment». Reproductive Biology and Endocrinology, vol. 9, June 2011, pàg. 87. DOI: 10.1186/1477-7827-9-87. PMC: 3135533. PMID: 21693036.
  114. «Aromatase in aging women». Seminars in Reproductive Endocrinology, vol. 17, 4, 1999, pàg. 349–58. DOI: 10.1055/s-2007-1016244. PMID: 10851574.
  115. «Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy». Journal of Pediatric and Adolescent Gynecology, vol. 16, 6, December 2003, pàg. 337–47. DOI: 10.1016/j.jpag.2003.09.008. PMID: 14642954.
  116. «Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly». Fertility and Sterility, vol. 83, 3, March 2005, pàg. 758–60. DOI: 10.1016/j.fertnstert.2004.08.025. PMID: 15749511.
  117. Diagnostic and operative gynecologic laparoscopy. St. Louis, MO: Mosby, 1995. 
  118. An atlas of endometriosis. 3rd. London: Informa Healthcare, 2007, p. 9–10. 
  119. 119,0 119,1 «The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres». Human Reproduction, vol. 27, 5, May 2012, pàg. 1292–9. DOI: 10.1093/humrep/des073. PMID: 22422778.

Enllaços externs[modifica]

A Wikimedia Commons hi ha contingut multimèdia relatiu a: Endometriosi Modifica l'enllaç a Wikidata